(Q71199774)
Statements
Treatment of high risk myelodysplastic syndromes with idarubicin and cytosine arabinoside supported by granulocyte-macrophage colony-stimulating factor. (GM-CSF) (English)
T Economopoulos
E Papageorgiou
N Stathakis
M Constantinidou
A Parharidou
A Kostourou
J Dervenoulas